Acadia Pharmaceuticals buy BMO Capital Markets
Start price
27.06.24
/
50%
€15.27
Target price
27.06.25
€28.91
Performance (%)
23.25%
End price
28.06.25
€18.82
Summary
This prediction ended on 28.06.25 with a price of €18.82. The BUY prediction by BMO_Capital_Markets finished with a performance of 23.25%. BMO_Capital_Markets has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | 7.540% | 7.540% | 20.088% |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $31.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.41
19.05.25
19.05.25
€25.05
19.05.26
19.05.26
-1.91%
25.03.26
25.03.26
